Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial 论文

2015The Lancet引用 1379
DOI
Melanoma and MAPK PathwaysComputational Drug Discovery MethodsSynthesis of Tetrazole Derivatives
Computational Drug Discovery MethodsMelanoma and MAPK PathwaysSynthesis of Tetrazole Derivatives
相关技术:Computational Drug Discovery Methods
关系图谱

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial · 相关事件

暂无数据